Alexander O. Schuth

Insider Reports History

Entity
Individual
Location
C/O Denali Therapeutics Inc., 151 Oyster Point Blvd., 2 Nd Floor, South San Francisco, CA
Signature
/s/ Tyler Nielsen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexander O. Schuth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. COFO and Secretary Common Stock 524K $13M $24.78 Aug 20, 2024 Indirect
Denali Therapeutics Inc. COFO and Secretary Common Stock 178K $4.41M $24.78 Aug 21, 2024 Direct
Denali Therapeutics Inc. COFO and Secretary Stock Option (right to buy) 145K Feb 8, 2024 Direct

Insider Reports Filed by Alexander O. Schuth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNLI Denali Therapeutics Inc. Aug 20, 2024 3 -$200K 4 Aug 22, 2024 COFO and Secretary
DNLI Denali Therapeutics Inc. Aug 13, 2024 1 -$52K 4 Aug 15, 2024 COFO and Secretary
DNLI Denali Therapeutics Inc. Feb 13, 2024 2 -$402K 4 Feb 15, 2024 COFO and Secretary
DNLI Denali Therapeutics Inc. Feb 8, 2024 2 $34K 4 Feb 12, 2024 COFO and Secretary
DNLI Denali Therapeutics Inc. Jan 5, 2024 1 -$194K 4 Jan 9, 2024 COFO and Secretary
DNLI Denali Therapeutics Inc. Jan 3, 2024 2 $0 4 Jan 5, 2024 COFO and Secretary
DNLI Denali Therapeutics Inc. Aug 23, 2023 1 -$58.4K 4 Aug 25, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Aug 21, 2023 1 -$56K 4 Aug 23, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Aug 14, 2023 1 -$65.6K 4 Aug 16, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Aug 10, 2023 1 -$69K 4 Aug 14, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Jul 17, 2023 4 -$534K 4 Jul 19, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. May 15, 2023 4 -$233K 4 May 17, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Apr 12, 2023 6 -$198K 4 Apr 14, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Feb 13, 2023 3 -$88.2K 4 Feb 15, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Feb 8, 2023 1 -$47K 4 Feb 10, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Jan 17, 2023 4 -$243K 4 Jan 19, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Jan 5, 2023 1 -$75K 4 Jan 9, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Jan 3, 2023 1 -$83.6K 4/A Jan 9, 2023 COFO and Secretary
DNLI Denali Therapeutics Inc. Oct 7, 2022 2 $13.6K 4 Oct 12, 2022 COFO and Secretary
DNLI Denali Therapeutics Inc. Aug 19, 2022 1 -$85.6K 4 Aug 23, 2022 COFO and Secretary
DNLI Denali Therapeutics Inc. Aug 9, 2022 1 $0 4 Aug 11, 2022 COFO and Secretary
DNLI Denali Therapeutics Inc. Feb 11, 2022 1 -$97.2K 4 Feb 15, 2022 COO and Secretary
DNLI Denali Therapeutics Inc. Feb 9, 2022 1 -$52.8K 4 Feb 11, 2022 COO and Secretary
DNLI Denali Therapeutics Inc. Jan 5, 2022 1 -$127K 4 Jan 7, 2022 COO and Secretary
DNLI Denali Therapeutics Inc. Jan 3, 2022 2 $0 4 Jan 5, 2022 COO and Secretary
DNLI Denali Therapeutics Inc. Dec 6, 2021 2 -$423K 4 Dec 8, 2021 COO and Secretary
DNLI Denali Therapeutics Inc. Nov 4, 2021 2 -$528K 4 Nov 8, 2021 COO and Secretary
DNLI Denali Therapeutics Inc. Oct 4, 2021 2 -$506K 4 Oct 6, 2021 COO and Secretary
DNLI Denali Therapeutics Inc. Sep 20, 2021 2 $6.15K 4 Sep 22, 2021 COO and Secretary
DNLI Denali Therapeutics Inc. Sep 7, 2021 3 -$555K 4 Sep 9, 2021 COO and Secretary
DNLI Denali Therapeutics Inc. Aug 19, 2021 2 -$126K 4 Aug 23, 2021 COO and Secretary
DNLI Denali Therapeutics Inc. Aug 4, 2021 3 -$522K 4 Aug 6, 2021 COO and Secretary
DNLI Denali Therapeutics Inc. Jul 6, 2021 1 -$762K 4 Jul 8, 2021 COO and Secretary
DNLI Denali Therapeutics Inc. Jun 4, 2021 2 -$645K 4 Jun 8, 2021 COO and Secretary